In addition, fluorescence in situ hybridization is used for the detection of fusion genes, such as the ETV6-NTRK3 fusion gene in secretory carcinoma and the CRTC1/3-MAML2 fusion gene in mucoepidermoid carcinoma [3, 30]. This evidence concerns the gene NTRK3 and mucoepidermoid carcinoma.